Docteur DENIS MULLEMAN
17ans d'exercice (thèse 2009)
✨ Profil synthétique
IA · 29/04/2026Le Docteur Denis MULLEMAN est un rhumatologue hospitalier à Tours, affilié au Centre de compétence FAI²R. Il est auteur de 232 publications et a dirigé une thèse de doctorat en Sciences de la Vie et de la Santé. Ses recherches portent principalement sur les maladies rhumatismales, notamment la polyarthrite rhumatoïde et les spondylarthropathies.
Expertises présumées
- Polyarthrite rhumatoïde
- Spondylarthropathies
- Thérapies biologiques
- Anti-TNF
- csDMARDs
- Sjögren
- Biothérapies non-anti-TNF
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Direction de thèses
🎓 1 thèse dirigéeSource theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
41
h articles cités ≥ h fois chacun. Un h de 41 = 41 publications avec 41+ citations.
Citations
4 770
Publications
234
i10-index
80
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×75
- Spondyloarthritis Studies and Treatments ×37
- Monoclonal and Polyclonal Antibodies Research ×31
- Infectious Diseases and Tuberculosis ×30
- Systemic Lupus Erythematosus Research ×27
Affiliations FR : Université de Tours
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
2024ArticleRheumatology
Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
2024ArticleClinical and experimental rheumatology
Septic arthritis of the facet joint is also a severe vertebral infection: A multicenter retrospective study of 65 patients
2024ArticleJoint Bone Spine
Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells
2024ArticleFrontiers in Immunology
Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.
2024ArticleRheumatology
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
2024ArticleJoint Bone Spine
Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe
2024ArticleBasic and Clinical Pharmacology and Toxicology
Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis
2024ArticleAnnals of the Rheumatic Diseases
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
CHRU BRETONNEAU - TOURS
2 Boulevard TONNELLE, 37044 Tours
☎ 0247474747Hospitalier
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Articles de presse (2)
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
- Le Lions club s'engage pour la recherche - lanouvellerepublique.fr
📰 lanouvellerepublique.fr · 20/01/2016
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNMjNGZWx0dE1ZM0FRM0hJTVNCMUR4cWVZd1FNVjlFaVN4aHNLR3EydlREOWxOWlpIZkN5OEVfU25JMW5iel9OXzRUZHpSZEx6WGpEQVdQUzYwdDBXVGVMMVNHUHVNMkJjWkIyRWoyRUlNVHh3dndGTVNtNEUxNk9ZQlo0MjRHVXlHOW5XNWRVZXJlYjBsckE?oc=5" target="_blank">Le Lions club s'engage p
- Lion's Club : un chèque pour la recherche - lanouvellerepublique.fr
📰 lanouvellerepublique.fr · 03/11/2014
<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxPZzlsM0xQM0VEb1Q0WVMzSEc3NFJQcVZaSHg3Y2FYTzFVNzdkSzJQZzZKM0dWLUV0U2tKNVc3RGQwMEVaVWN6dkxwc21pdllHVDBLMUtqMjU1elRlSzVSUm9EMTNqRmNXdmpKTHVXTXQ5Vi1laUF5S0gtUDNfUXVkLTRBUklmc296?oc=5" target="_blank">Lion's Club : un chèque pour la recherche</
Top publications · les plus citées
- 1Large increase of vertebral osteomyelitis in France: a 2010-2019 cross-sectional study
Epidemiology and infection · 2021
Lire l'abstract Crossref ↓
Abstract Vertebral osteomyelitis (VO) represents 4–10% of bone and joint infections. In Western countries, its incidence seems to increase, simultaneously with an increasing number of comorbidities among an ageing population. This study aimed to assess the evolution of VO epidemiology in France over the 2010–2019 decade. A nationwide cross-sectional study was conducted using the French hospital discharge data collected through the French diagnosis-related groups ‘Programme de Médicalisation des Systèmes d'Information’. VOs were detected with a previously validated case definition using International Classification of Diseases 10 (ICD-10) codes, implemented with the French current procedural terminology codes. The study population included all patients hospitalised in France during the 2010–2019 decade, aged 15 years old and more. Patient and hospital stay characteristics and their evolutions were described. During the study period, 42 105 patients were hospitalised for VO in France involving 60 878 hospital stays. The mean VO incidence was 7.8/100 000 over the study period, increasing from 6.1/100 000 in 2010 to 11.3/100 000 in 2019. The mean age was 64.8 years old and the sex ratio was 1.56. There were 31 341 (74.4%) patients with at least one comorbidity and 3059 (7.3%) deceased during their hospital stay. Even if rare, device-associated VOs (4450 hospital stays, 7.3%) highly increased over the period. The reliability of the method, based upon an exhaustive database and a validated case definition, provided an effective tool to compare data over time in real-life conditions to regularly update the epidemiology of VO.
- 2EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Annals of the rheumatic diseases · 2023
- 3Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Clinical pharmacology : advances and applications · 2017
Publications scientifiques (50) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal26
▼
Transversal26
▼- Therapeutic drug monitoring education: The current state
British journal of clinical pharmacology · 2026 · Journal Article
Petrova G, Blagova S, Tachkov K, Santos M, et al.
📚 1 cit. - Quality Assessment of Therapeutic Drug Monitoring Assays of Therapeutic Antibodies Across Europe: An Update
Basic & clinical pharmacology & toxicology · 2025 · Journal Article
Bluett J, Rumano M, Martínez Becerra MJ, Loeff F, et al.
- Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts
Clinical and experimental rheumatology · 2024 · Journal Article
Ruyssen-Witrand A, Dimeglio C, Nogue E, Molinary N, et al.
- Septic arthritis of the facet joint is also a severe vertebral infection: A multicenter retrospective study of 65 patients
Joint bone spine · 2024 · Journal Article
Cadiou S, Tuil R, Le Goff B, Hoppé E, et al.
- A specific diagnostic metabolome signature in adult IgA vasculitis
Metabolomics : Official journal of the Metabolomic Society · 2024 · Journal Article
Boissais A, Blasco H, Emond P, Lefèvre A, et al.
📚 5 cit.🎯 RCR 1.56 - Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe
Basic & clinical pharmacology & toxicology · 2024 · Journal Article
Skrede S, Bogavac-Stanojević N, Dreesen E, Nielsen E, et al.
📚 4 cit.🎯 RCR 1.71 - Bispecific antibodies tethering innate receptors induce human tolerant-dendritic cells and regulatory T cells
Frontiers in immunology · 2024 · Journal Article
Lamendour L, Gilotin M, Deluce-Kakwata Nkor N, Lakhrif Z, et al.
📚 2 cit. - 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis
Joint bone spine · 2024 · Review
Darrieutort-Laffite C, Coiffier G, Aïm F, Banal F, et al.
- Counteracting tryptophan metabolism alterations as a new therapeutic strategy for rheumatoid arthritis
Annals of the rheumatic diseases · 2024 · Journal Article
Moulin D, Millard M, Taïeb M, Michaudel C, et al.
📚 44 cit.🎯 RCR 8.46🔬→🩺 Translationnel - Association between radiographic and functional outcome in vertebral osteomyelitis SPONDIMMO, a 6-month prospective multicenter cohort
Joint bone spine · 2023 · Multicenter Study
Chevalerias M, Coiffier G, Darrieutort-Laffite C, Godot S, et al.
- Response to Biologic Drugs in Patients With Rheumatoid Arthritis and Antidrug Antibodies
JAMA network open · 2023 · Journal Article
Bitoun S, Hässler S, Ternant D, Szely N, et al.
📚 24 cit.🎯 RCR 3.61🔬→🩺 Translationnel - EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases
Annals of the rheumatic diseases · 2023 · Systematic Review
Krieckaert CL, van Tubergen A, Gehin JE, Hernández-Breijo B, et al.
📚 58 cit.🎯 RCR 10.15🔬→🩺 Translationnel - Management and outcome of native joint septic arthritis: a nationwide survey in French rheumatology departments, 2016-2017
Annals of the rheumatic diseases · 2022 · Journal Article
Richebé P, Coiffier G, Guggenbuhl P, Mulleman D, et al.
📚 7 cit. - Spine immobilization and neurological outcome in vertebral osteomyelitis SPONDIMMO, a prospective multicentric cohort
Joint bone spine · 2022 · Journal Article
Le Pluart A, Coiffier G, Darrieutort-Lafitte C, Godot S, et al.
📚 3 cit. - Large increase of vertebral osteomyelitis in France: a 2010-2019 cross-sectional study
Epidemiology and infection · 2021 · Journal Article
Conan Y, Laurent E, Belin Y, Lacasse M, et al.
📚 70 cit.🎯 RCR 7.86🔬→🩺 Translationnel - Poor assessment of bone mineral density after a forearm fracture in women aged 50 years or older: Data from a French health insurance database
Joint bone spine · 2021 · Letter
Cattelain-Lopez E, Chu Miow Lin D, Happe A, Goupille P, et al.
- 2020 French recommendations on the management of septic arthritis in an adult native joint
Joint bone spine · 2020 · Journal Article
Couderc M, Bart G, Coiffier G, Godot S, et al.
📚 41 cit.🎯 RCR 3.33🔬→🩺 Translationnel - [Rheumatology, the multitude of options]
Medecine sciences : M/S · 2019 · Journal Article
Morel J, Mulleman D
📚 1 cit. - Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Clinical pharmacology : advances and applications · 2017 · Journal Article
Dreesen E, Bossuyt P, Mulleman D, Gils A, et al.
📚 57 cit.🎯 RCR 2.60🔬→🩺 Translationnel - Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics
Therapeutic drug monitoring · 2017 · Journal Article
Murias S, Magallares L, Albizuri F, Pascual-Salcedo D, et al.
📚 6 cit.🔬→🩺 Translationnel - Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling
Therapeutic drug monitoring · 2017 · Journal Article
Passot C, Pouw MF, Mulleman D, Bejan-Angoulvant T, et al.
📚 21 cit.🔬→🩺 Translationnel - Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatoid Arthritis
Therapeutic drug monitoring · 2017 · Journal Article
Medina F, Plasencia C, Goupille P, Ternant D, et al.
📚 23 cit.🎯 RCR 1.13🔬→🩺 Translationnel - Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases
Therapeutic drug monitoring · 2017 · Journal Article
Paintaud G, Passot C, Ternant D, Bertolotto A, et al.
📚 11 cit. - Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Spondyloarthritis
Therapeutic drug monitoring · 2017 · Journal Article
Medina F, Plasencia C, Goupille P, Paintaud G, et al.
📚 10 cit.🔬→🩺 Translationnel - Biopharmaceuticals: Reference Products and Biosimilars to Treat Inflammatory Diseases
Therapeutic drug monitoring · 2017 · Journal Article
Gils A, Bertolotto A, Mulleman D, Bejan-Angoulvant T, et al.
📚 8 cit. - Comparison of the Big Five personality traits in fibromyalgia and other rheumatic diseases
Joint bone spine · 2017 · Comparative Study
Bucourt E, Martaillé V, Mulleman D, Goupille P, et al.
📚 50 cit.🎯 RCR 3.18🔬→🩺 Translationnel
Anti-TNF8
▼
Anti-TNF8
▼- Serum biomarkers fail to predict response to adalimumab in axial spondyloarthritis: Results from discovery and validation cohorts
Joint bone spine · 2026 · Letter
Baillet A, Nguyen MVC, Courtier A, Guigue L, et al.
- Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model
Clinical pharmacokinetics · 2022 · Journal Article
Ternant D, Pfister M, Le Tilly O, Mulleman D, et al.
📚 9 cit.🔬→🩺 Translationnel - Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model
Pharmaceutics · 2021 · Journal Article
Ternant D, Le Tilly O, Picon L, Moussata D, et al.
📚 7 cit. - Exposure-Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
Clinical and translational science · 2020 · Journal Article
Paul S, Marotte H, Kavanaugh A, Goupille P, et al.
📚 7 cit.🔬→🩺 Translationnel - Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
RMD open · 2020 · Journal Article
Ducourau E, Rispens T, Samain M, Dernis E, et al.
📚 46 cit.🎯 RCR 3.11🩺 Clinique - Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration
Clinical pharmacokinetics · 2018 · Journal Article
Ternant D, Passot C, Aubourg A, Goupille P, et al.
📚 15 cit.🔬→🩺 Translationnel - Adalimumab concentration-based tapering strategy: as good as the recommended dosage
Annals of the rheumatic diseases · 2018 · Editorial
Mulleman D, Balsa A
📚 10 cit.🔬→🩺 Translationnel - Brief Report: Relationship Between Serum Infliximab Concentrations and Risk of Infections in Patients Treated for Spondyloarthritis
Arthritis & rheumatology (Hoboken, N.J.) · 2017 · Journal Article
Bejan-Angoulvant T, Ternant D, Daoued F, Medina F, et al.
📚 29 cit.🎯 RCR 1.38🔬→🩺 Translationnel
Biothérapies non-anti-TNF6
▼
Biothérapies non-anti-TNF6
▼- Immunoglobulin G Receptors (FcγR), in Addition to Target-Antigen and Neonatal Fc Receptor (FcRn), Influence Rituximab Pharmacokinetics
Clinical pharmacokinetics · 2025 · Journal Article
Ternant D, Le Tilly O, Cartron G, Desvignes C, et al.
- The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition
Clinical pharmacokinetics · 2022 · Journal Article
Bensalem A, Cartron G, Specks U, Mulleman D, et al.
📚 14 cit.🎯 RCR 1.57🔬→🩺 Translationnel - Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Arthritis research & therapy · 2020 · Journal Article
Toussirot E, Marotte H, Mulleman D, Cormier G, et al.
📚 40 cit.🎯 RCR 2.64🔬→🩺 Translationnel - Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
Clinical pharmacokinetics · 2020 · Journal Article
Bensalem A, Mulleman D, Paintaud G, Azzopardi N, et al.
📚 19 cit.🎯 RCR 1.24🩺 Clinique - CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis
British journal of clinical pharmacology · 2019 · Journal Article
Bensalem A, Mulleman D, Thibault G, Azzopardi N, et al.
📚 16 cit.🩺 Clinique - Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients
British journal of clinical pharmacology · 2017 · Journal Article
Lioger B, Edupuganti SR, Mulleman D, Passot C, et al.
📚 32 cit.🎯 RCR 1.56🔬→🩺 Translationnel
Revue générale3
▼
Revue générale3
▼- Joint manifestations revealing inborn metabolic diseases in adults: a narrative review
Orphanet journal of rare diseases · 2023 · Journal Article
Loret A, Jacob C, Mammou S, Bigot A, et al.
📚 5 cit.🎯 RCR 1.25 - Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
RMD open · 2023 · Journal Article
van der Togt CJT, Van den Bemt B, Aletaha D, Alten R, et al.
📚 22 cit.🎯 RCR 4.07🔬→🩺 Translationnel - Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
RMD open · 2022 · Journal Article
Krieckaert C, Hernández-Breijo B, Gehin JE, le Mélédo G, et al.
📚 22 cit.🎯 RCR 2.52🔬→🩺 Translationnel
Épidémiologie & registres2
▼
Épidémiologie & registres2
▼- High prevalence of clinical and biological features of metabolic syndrome in patients with epidural lipomatosis: A single-center, retrospective study
Joint bone spine · 2022 · Letter
Doize H, Bodet-Contentin L, Dhalluin T, Maillot F, et al.
📚 1 cit. - High incidence of vertebral osteoporotic fracture within the first year after liver transplantation
Clinical and experimental rheumatology · 2017 · Journal Article
Butin S, Griffoul I, Espitalier F, Salamé E, et al.
📚 9 cit.
Sjögren2
▼
Sjögren2
▼- Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis
Rheumatology (Oxford, England) · 2025 · Journal Article
Astouati Q, Machet T, Houssais C, Noury JB, et al.
📚 6 cit.🎯 RCR 2.59 - A Comparative Study of Fibromyalgia, Rheumatoid Arthritis, Spondyloarthritis, and Sjögren's Syndrome; Impact of the Disease on Quality of Life, Psychological Adjustment, and Use of Coping Strategies
Pain medicine (Malden, Mass.) · 2021 · Journal Article
Bucourt E, Martaillé V, Goupille P, Joncker-Vannier I, et al.
📚 42 cit.🎯 RCR 4.90🔬→🩺 Translationnel
csDMARDs1
▼
csDMARDs1
▼- Methotrexate effect on immunogenicity and long-term maintenance of adalimumab in axial spondyloarthritis: a multicentric randomised trial
RMD open · 2020 · Journal Article
Ducourau E, Rispens T, Samain M, Dernis E, et al.
📚 46 cit.🎯 RCR 3.11🩺 Clinique
Économie santé1
▼
Économie santé1
▼- Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international Delphi study
RMD open · 2023 · Journal Article
van der Togt CJT, Van den Bemt B, Aletaha D, Alten R, et al.
📚 22 cit.🎯 RCR 4.07🔬→🩺 Translationnel
Essai clinique1
▼
Essai clinique1
▼- Predictors of response to TNF inhibitors in rheumatoid arthritis: an individual patient data pooled analysis of randomised controlled trials
RMD open · 2021 · Journal Article
Law-Wan J, Sparfel MA, Derolez S, Azzopardi N, et al.
📚 15 cit.🎯 RCR 1.20🔬→🩺 Translationnel
IA en rhumatologie1
▼
IA en rhumatologie1
▼- Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases
Rheumatology international · 2022 · Journal Article
Vera Cruz G, Bucourt E, Réveillère C, Martaillé V, et al.
📚 20 cit.🎯 RCR 2.59
Lupus1
▼
Lupus1
▼- International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus
Autoimmunity reviews · 2017 · Journal Article
Kleinmann JF, Tubach F, Le Guern V, Mathian A, et al.
📚 26 cit.🎯 RCR 1.12🔬→🩺 Translationnel
Vascularites1
▼
Vascularites1
▼- Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited
Clinical pharmacokinetics · 2020 · Journal Article
Bensalem A, Mulleman D, Paintaud G, Azzopardi N, et al.
📚 19 cit.🎯 RCR 1.24🩺 Clinique
Datasets & protocoles partagés
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Collection2020figshareAbstract Background Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) disease. Adiponectin is involved in the metabolism of glucose and lipids with favourable effects on CV disease, es
FMC - indications thérapeutiques dans l'ostéoporose : les recommandations 2006 de l'AFSSAPS
Audiovisual2007Canal-U/MédecineDenis MULLEMAN, nous présente le thème : indications thérapeutiques dans l'ostéoporose - recommandations 2006 de l' Agence française de sécurité sanitaire des produits de santé (AFSSAPS). Il existe beaucoup de traitement
Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study
Collection2020figshareAbstract Background Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular (CV) disease. Adiponectin is involved in the metabolism of glucose and lipids with favourable effects on CV disease, es
Joint manifestations revealing inborn metabolic diseases in adults: a narrative review
Collection2024figshareAbstract Inborn metabolic diseases (IMD) are rare conditions that can be diagnosed during adulthood. Patients with IMD may have joint symptoms and the challenge is to establish an early diagnosis in order to institute ap
Joint manifestations revealing inborn metabolic diseases in adults: a narrative review
Collection2024figshareAbstract Inborn metabolic diseases (IMD) are rare conditions that can be diagnosed during adulthood. Patients with IMD may have joint symptoms and the challenge is to establish an early diagnosis in order to institute ap
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
